🇺🇸 FDA
Patent

US 12036234

Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues

granted A61KA61K31/70A61K31/727

Quick answer

US patent 12036234 (Heparin conjugated to collagen-binding peptides for targeting to biological and synthetic tissues) held by Northwestern University expires Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Northwestern University
Grant date
Tue Jul 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/70, A61K31/727, A61K38/08, A61K47/547